- Home
- GEN vs FMS Comparison
GEN vs FMS Comparison
Compare GEN & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GEN
- FMS
- Stock Information
- Founded
- GEN 1982
- FMS 1996
- Country
- GEN United States
- FMS Germany
- Employees
- GEN N/A
- FMS N/A
- Industry
- GEN Computer Software: Prepackaged Software
- FMS Misc Health and Biotechnology Services
- Sector
- GEN Technology
- FMS Health Care
- Exchange
- GEN Nasdaq
- FMS Nasdaq
- Market Cap
- GEN 18.6B
- FMS 15.0B
- IPO Year
- GEN N/A
- FMS 1996
- Fundamental
- Price
- GEN $29.50
- FMS $24.75
- Analyst Decision
- GEN Buy
- FMS Sell
- Analyst Count
- GEN 6
- FMS 2
- Target Price
- GEN $36.50
- FMS $30.00
- AVG Volume (30 Days)
- GEN 4.2M
- FMS 284.2K
- Earning Date
- GEN 10-29-2025
- FMS 11-04-2025
- Dividend Yield
- GEN 1.69%
- FMS 2.30%
- EPS Growth
- GEN 1.17
- FMS 23.39
- EPS
- GEN 0.96
- FMS 2.62
- Revenue
- GEN $4,227,000,000.00
- FMS $22,922,038,756.00
- Revenue This Year
- GEN $24.55
- FMS $2.10
- Revenue Next Year
- GEN $4.51
- FMS $3.13
- P/E Ratio
- GEN $30.74
- FMS $18.64
- Revenue Growth
- GEN 10.60
- FMS 0.53
- 52 Week Low
- GEN $22.74
- FMS $18.94
- 52 Week High
- GEN $32.22
- FMS $30.46
- Technical
- Relative Strength Index (RSI)
- GEN 40.01
- FMS 44.97
- Support Level
- GEN $29.14
- FMS $24.22
- Resistance Level
- GEN $30.93
- FMS $25.72
- Average True Range (ATR)
- GEN 0.46
- FMS 0.26
- MACD
- GEN -0.24
- FMS 0.01
- Stochastic Oscillator
- GEN 13.14
- FMS 35.33
About GEN Gen Digital Inc.
Gen is a cybersecurity pure-play that offers security, identity protection, and privacy solutions to individual consumers. The firm's cyber safety offerings, via brands such as Norton, Avast, and LifeLock, have long maintained their positions as some of the most recognizable consumer-focused security and identity-protection products.
About FMS Fresenius Medical Care AG
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.